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Edited by Sandro SonninoAbstract Starting from a comparative study of diﬀerent Ca2þ
chelators on the G-protein-induced inhibition of the CaV2.1 Ca
channels, we demonstrate that BAPTA and DM-nitrophen are
able to interact, in a Ca2þ- and lipid-dependent manner, with
phospholipid monolayers. Critical insertion pressure and sensi-
tivity to charged lipids indicated that insertion in the lipid ﬁlm
may occur in biological membranes as those found on Xenopus
oocytes. This novel property is not found for EGTA and EDTA
and may participate to the unusual ability of BAPTA-related
molecules to chelate Ca2þ ions in the very close vicinity of the
plasma membrane, where most of the Ca2þ-dependent signalling
triggered by voltage-gated Ca2þ currents occurs.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ca2þ ions play a central role in many physiological processes
either directly, through Ca2þ speciﬁc ion channel-induced
membrane depolarisation or indirectly as a second messenger
spreading excitation to a vast array of Ca2þ-sensitive proteins
leading to contraction, secretion, gene activation [1–3], etc.
The role of Ca2þ ions in these processes has been largely
studied using speciﬁc chelators and indicators. Before 1980,
ethylene glycol bis (b-aminoethyl ether)-N,N,N0,N0-tetraacetic
acid (EGTA) was almost the only chelator used in biological
experiments as it displayed a high speciﬁcity towards Ca2þ, a
simple 1:1 stoichiometry and good buﬀering capacity. How-
ever one of the major drawbacks of EGTA was the speed of
buﬀering, since the protonated form of EGTA, which pre-
dominates at pH 7.0, has relatively slow Ca2þ-binding kinetics
(Kon¼ 1.5 106 M1 s1 [4]). In 1980, Tsien designed and
synthesized a new form of EGTA, 1,2-bis(o-aminophen-
oxy)ethane-N,N,N0,N0-tetraacetic acid (BAPTA; [5]), in which
the addition of benzene rings, while keeping the overall
structure of the molecule, decreased the ionization below pH
6.5 and thus accelerated Ca2þ chelation (Kon¼ 9.1 108
M1 s1). Since then, BAPTA has become a useful tool to
analyse the eﬀect of fast and localized Ca2þ transients such as
those generated by the opening of Ca2þ speciﬁc ion channels.
Ca2þ chelation using BAPTA or EGTA soon appeared to be* Corresponding author. Fax: +33-467-52-15-59.
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their diﬀerent kinetics of chelation (see for example [4]).
However, recently BAPTA has also been suggested to induce
changes in cellular physiology unrelated to its Ca2þ chelating
properties and designed under the term of ‘‘pharmacological
eﬀect’’ of BAPTA.
We now report a new property of BAPTA that may in part
explain these diﬀerent results and additional eﬀects. The free
form of BAPTA can interact with phospholipid monolayers, a
widely used membrane model [6]. The critical insertion pres-
sure (CPI, see Section 2) and phospholipid speciﬁcity are
compatible with an insertion into biological plasma mem-
branes. The Ca2þ bound form of BAPTA cannot associate
with phospholipid monolayers, suggesting that BAPTA may
function as a shuttle buﬀer [7,8], driving Ca2þ out of the
membrane and thus decreasing the Ca2þ concentration spe-
ciﬁcally at the membrane interface. Similar results are found
with DM-nitrophen but not with EGTA and EDTA.2. Materials and methods
2.1. Materials and oocyte preparation and recordings
BAPTA, (Sigma–Aldrich, Lisle D’Abeau-Chesnes, FR), di-Br-
BAPTA, di-methyl BAPTA and DM-nitrophen (Molecular Probes
Inc., Eugene, OR) were prepared at 100 mM in HEPES 10 mM
(pH 7.2 with CsOH) for on-line injection into oocytes. In Fig. 1,
BAPTA was loaded with 20% Ca2þ. EGTA and EDTA were pre-
pared at 200 mM in the same solution. Phospholipids, diol-
eoylphosphatidylcholine (DOPC) and dioleoylphosphatidylglycerol
(DOPG), were purchased from Avanti Polar Lipids (Alabaster,
AL).
Xenopus laevis oocyte preparation and injection were performed as
described [9]. Each oocyte was injected with 5–10 nl of a cDNA mix-
ture containing the CaV2.1+ a2d cDNAs at 0.3 ng/nl with a ratio of
1:2. Oocytes were kept for 2–4 days at 18 C under gentle agitation
before use.
Whole-cell Ba2þ currents were recorded under two electrode
voltage-clamp using the GeneClamp 500 ampliﬁer (Axon Instru-
ments, Union City, CA). Current and voltage electrodes (less than 1
MX) were ﬁlled with: 3 M KCl, pH 7.2, with KOH. Ba2þ current
recordings were performed using the following external solution (in
mM): BaOH, 10; TEAOH, 20; NMDG, 50; CsOH, 2; HEPES, 10;
pH 7.2 with methanesulfonic acid. Currents were ﬁltered and digi-
tized using a Digidata-1200 interface (Axon Instruments), and sub-
sequently stored on a Pentium-based personal computer using
version 6.02 of pClamp software (Axon Instruments). Around 10–30
nl of each of the above-mentioned chelators (in mM: chelator, 100;
CsOH, 10; HEPES, 10; pH 7.2 CsOH) were injected into the oocyte
(10 psi, 150 ms) during the course of the experiment at the time
indicated. Ba2þ currents were recorded during a 400 ms test pulse
from )80 to +10 mV. Current amplitudes were measured at the peak
of the current. Comparisons between experiments were made by
normalizing all average amplitudes with respect to the control cur-
rent amplitude set at 100%.blished by Elsevier B.V. All rights reserved.
Fig. 1. (A) Ba2þ currents recorded using two electrode voltage-clamp in Xenopus oocytes injected with CaV2.1 + a2  d subunit cDNAs during
depolarizations of 400 ms duration to +10 mV from a holding potential of )80 mV every 15 s. EGTA was injected at 200 mM (2 mM ﬁnal con-
centration) by the use of a third microelectrode. BAPTA was injected at 100 mM using a fourth microelectrode. Note that EGTA was without eﬀect,
whereas following injection of BAPTA a clear increase in current amplitude was recorded (attributed to the relief of the tonic G-protein block [13]).
RIGHT. Averaged increase in Ba2þ current amplitude following injection of EGTA or BAPTA. *: signiﬁcantly diﬀerent from control current before
injection. (B) The same experiment was performed using diBr-BAPTA, DiCH3-BAPTA, DM-nitrophen, EGTA or EDTA instead of BAPTA. In
each case the eﬀects on Ba2þ current amplitude are shown (mean of 5–20 experiments). Note that EDTA and EGTA do not have a benzene ring in
their structure and were ineﬀective in increasing current amplitude.
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Adsorption at the air/water interface and penetration studies into
lipid monolayers were carried-out according to the Wilhelmy plate
method using a Prolabo (Paris, France) tensiometer and an X-Y Kipp
and Zonen BD91 recorder (Delft, The Netherlands), as previously
described [10]. A solution of the lipids in chloroform/methanol (3/1,
v/v) was spread on the air-buﬀer aqueous solution interface in order to
ensure a deﬁnite surface pressure. The solvent was then allowed to
evaporate and when a constant surface pressure was reached, generally
27–30 mN/m, a value corresponding approximately to the lateral
pressure of biological membranes [11], aliquots of the aqueous chelator
solution were injected at the desired concentration into the aqueoussubphase, which was gently stirred using a magnetic stirrer, and
changes in surface pressure were recorded continuously. This proce-
dure was repeated until no further increase of the surface pressure
could be detected. Adsorption measurements were thus made at
equilibrium [12]. DOPC (1,2-dioleyl-sn-glycero-3-phosphocholine) and
DOPG (1,2-dioleyl-sn-glycero-3-phosphoglycerol) at 100/0, 0/100
or 90/10 ratios were used to prepare monolayers of diﬀerent lipid
compositions.
In order to determine the CPI of the chelator into lipids, increases of
surface pressure, DP , were recorded for diﬀerent initial lipid surface
pressures Pi, and the value of CPI was obtained by extrapolation of the
curve for a null DP . This CPI corresponds to the maximum initial
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the establishment of lipid–BAPTA interactions. A pH 7, 100 mM
phosphate buﬀer (NaH2PO4/NaOH) was used for the subphase me-
dium. Recordings using a 10 mM HEPES, pH 7.2, buﬀer solution gave
similar results (not shown). All results are expressed as meansS.E.M.
of n independent experiments.Fig. 2. (A) Adsorption of BAPTA at the air interface by injecting
diﬀerent concentrations of the drug into the subphase. A clear and
stable increase in surface pressure was obtained for concentrations
larger than 1 mM indicating the formation of a stable monolayer. (B)
Injection of increasing concentrations of BAPTA into the subphase of
a DOPC monolayer induced a marked increase in surface pressure.
EGTA, injected in the same conditions, had no eﬀect. (C) Similar
experiments performed with 100% pure DOPC or DOPG, or a 90/10%
DOPC/DOPG mixture of lipid monolayers. In the latter more
physiological situation, BAPTA was clearly capable of interfacial
penetration.3. Results and discussion
Our ﬁrst experimental evidence that chelation of intracellular
Ca2þ by BAPTA is more complex than initially believed came
from studies performed on P/Q type Ca2þ channels expressed in
Xenopus oocytes [13]. In this model, the Ca2þ channels ex-
pressed without their regulatory b subunit are under a tonic
inhibition produced by the excess of free Gbc dimer [14]. This
particular type of inhibition could be reversed when BAPTA
was injected into the oocyte, an eﬀect that was independent of
the fast chelation kinetics of BAPTA [13]. Injection of EGTA
using the same experimental protocol could not reproduce the
eﬀect of BAPTA (Fig. 1A) suggesting that the two chelators,
despite their similar aﬃnity constants for Ca2þ, have speciﬁc
chelating properties. Injection of EGTA was not only ineﬀec-
tive in removing the tonic block imposed by the G-protein, but
also unable to prevent the eﬀect of a subsequent injection of
BAPTA (Fig. 1A), since the increase in current amplitude re-
corded after injection of BAPTA was similar whether EGTA
was ﬁrst injected or not (2.2 0.2 and 2.4 0.3, fold respec-
tively). Any pharmacological eﬀect of BAPTA other than Ca2þ
chelation was discarded in our previous study since pre-loading
of BAPTA with Ca2þ strongly decreased the removal of the G-
protein inhibition [13]. We thus decided to test various chela-
tors with diﬀerent structures using the same injection protocol,
i.e., injection of 40 nl of a 100 mM solution of the chelator
during the recording of a Ba2þ current elicited by test pulses of
400 ms from )80 to +10 mV every 15 s. The summary of these
experiments is shown in Fig. 1B together with the chemical
structure of the chelators. Although it was clear that all the
chelators (injected at 100 mM, ﬁnal intra-oocyte concentration
1–2 mM) that display a benzene ring in their structure were
eﬀective in increasing the Ba2þ current (in a roughly propor-
tional manner with respect to their binding aﬃnity for Ca2þ),
EGTA and EDTA, two chelators lacking benzene rings in their
structure, were almost completely ineﬀective, even when in-
jected at a higher concentration (200 mM, in Fig. 1B). This
structure-activity relationship lead us to propose that these
chelators may share, due to their benzene rings, the capability
to interact with plasma membranes and thus be able to chelate
Ca2þ ions at the level of the inner face of the membrane. To test
this hypothesis we decided to analyze the eﬀect of these chela-
tors on the surface pressure of lipid monolayers.
We ﬁrst looked at the surface activity of BAPTA at the air–
buﬀer interface by injecting increasing concentrations of the
chelator on the subphase of a lipid-free surface. Starting at 0.5
mM, BAPTA formed stable monolayers by adsoption at the
interface (Fig. 2A), as indicated by the increase in surface
pressure. This interfacial adsorption reached a surface pressure
of 6 mN/m at 1.5 mM of BAPTA after a stabilization period of
several minutes, and then remained constant, indicating the
formation of a stable monolayer as expected for a surface-
active compound. When injected into the stirred subphase of a
lipid monolayer (DOPC) at an initial surface pressure of 27mM/m, BAPTA at 1 mM (close to the expected concentration
in oocyte experiments) readily and spontaneously penetrated
the DOPC monolayer and increased the surface pressure by
about 6 mN/m (Fig. 2B). Thus BAPTA has a thermodynamic
tendency to interact with lipid monolayers and to reach a new
surface stability through association with lipids of the mono-
layer. Similar experiments performed with EGTA (1 mM)
failed to reveal such surface activity (Fig. 1B), and only a small
decrease in the initial pressure (1 mN/m) was recorded after
injection of EGTA in the subphase.
In order to verify the relationship between the surface
activity of these chelators and their ability to block the G-
protein-dependent inhibition of the CaV2.1 Ca
2þ channels, we
then injected EDTA or the EDTA derivative DM-nitrophen,
both at 1 mM ﬁnal concentration, in the subphase of DOPC
Fig. 3. (A) Dependence of the pressure increase induced by 1 mM
BAPTA injection on initial surface pressure. Injection was made into
the subphase of the monolayer. Estimated CPI 42.4 mN/m. (B)
Changes in surface pressure of spread DOPC monolayer following
addition of 1 mM BAPTA and subsequent injection of increasing
concentrations of CaCl2. Injection of CaCl2, in the presence of BAP-
TA (squares), completely reversed the eﬀect of BAPTA, while injection
of CaCl2, alone (circles) had no eﬀect. This suggests that the Ca
2þ-
bound form of BAPTA was destabilized in the lipid environment and
that it left the monolayer.
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was perfectly capable of interacting with DOPC lipids, al-
though displaying a smaller activity than BAPTA, EDTA was
almost completely devoid of surface activity and no change in
surface pressure was recorded after EDTA injection. We
concluded that BAPTA and DM-nitrophen were able to pen-
etrate lipid monolayers, while EGTA and EDTA were not, a
property in relation with their ability to decrease G-protein
inhibition. It should be noted that this insertion occurred at an
initial surface pressure of 27 mN/m, suggesting it may also
occur in bilayers. Moreover, the diﬀerences obtained after in-
jection of BAPTA or DM-nitrophen in the changes in Ca2þ
current amplitudes (Fig. 1A) and in surface pressures (Fig. 2C)
suggested that the functional eﬀect of these substances is
modulated by both, their aﬃnity for Ca2þ and their capability
to penetrate biological membranes, this last eﬀect being dic-
tated by the presence of benzene rings in the EGTA (BAPTA)
or EDTA (DM-nitrophen) derivatives.
We then analyzed the speciﬁcity of interaction between
BAPTA and lipids by measuring the change in surface pressure
recorded on lipid monolayers composed of 100% DOPC, 100%
DOPG, or a DOPC/DOPG mixture of 90/10. In purely nega-
tively charged phospholipids (100% DOPG, see Fig. 2C), the
maximum surface pressure reached after BAPTA injection was
clearly smaller than with the zwitterionic phosphatidyl choline
DOPC (2.5 versus 6 mN/m, respectively), indicating that
negatively charged lipids signiﬁcantly decreased the penetra-
tion of BAPTA into the monolayer, probably via electrostatic
repulsion between the negative charges of the lipids and the
free form of BAPTA. However, in more ‘‘physiological’’ sit-
uations, when the monolayers were composed of a ratio of
uncharged/charged lipids of 90/10, BAPTA was able to pene-
trate the lipid monolayers, inducing an increase in surface
pressure close to that obtained in pure DOPC (5 versus 6 mN/
N) suggesting that similar interfacial penetration should also
be obtained in the Xenopus plasma membrane.
To conﬁrm this hypothesis we measured the interfacial
penetration of BAPTA at increasing initial surface pressures of
DOPC monolayers, keeping a constant 1 mM BAPTA con-
centration. This relation allowed us to extrapolate to the ab-
scissa the initial surface pressure at which no penetration
occurs CPI. This calculated cut-oﬀ pressure is related to the
lipid–BAPTA interaction and occurs at 42 mN in our condi-
tions (Fig. 3A), a value larger than the 33 mN/m surface
pressure that corresponds to the typical molecule/area of 0.7
nm2 of ﬂuid bilayers [15]. Together with insertion in DOPC
monolayers at an initial pressure of 27 mM/m (see Fig. 2B)
these results conﬁrmed that penetration of BAPTA must also
occur in lipid bilayers.
All the above experiments were performed with the free
form of BAPTA without any Ca2þ added. However, it was
interesting to analyze the surface activity of the Ca2þ-loaded
form of BAPTA, to know if BAPTA could stabilize Ca2þ
ions at the intracellular membrane interface, or, at the op-
posite, leave the membrane after Ca2þ binding. To test this
possibility we ﬁrst injected BAPTA in the stirred subphase of
a DOPC monolayer, and recorded an increase in the initial
surface pressure from 27 to 36 mN/m (see Fig. 3B). Then
increasing quantities of CaCl2 were added to the subphase
and the variations of the surface pressure were recorded up
to stability. As shown in Fig. 3B, increasing the total Ca2þ
concentration of the subphase to 150 lM completely re-versed the increase in pressure induced by BAPTA, sug-
gesting that the Ca-bound form of BAPTA was not
stabilized into the lipid ﬁlms, leading to a complete decrease
of the interfacial penetration. In similar experiments where
only Ca2þ ions were added without BAPTA, only very small
changes in surface pressure were noticed, indicating the lack
signiﬁcant eﬀect of Ca2þ on DOPC monolayer surface
pressure and stability.
These results clearly show that upon binding of a Ca2þ
ion, the molecule of BAPTA can readily leave the membrane
and thus suggest that BAPTA can behave like a shuttle
buﬀer, attached to the membrane in its free form and re-
moving bound Ca2þ ion from the cytoplasmic side of the
membrane. An important consequence, yet not experimen-
tally tested, of such behavior would be a substantial de-
crease of the Ca concentration at the inner face of the
membrane. This property is not shared by EGTA and may
explain some of the speciﬁc eﬀects of BAPTA in biological
systems where Ca2þ compartmentalization and fast and site-
speciﬁc Ca2þ buﬀering may play an important role in dis-
crimating Ca2þ buﬀers of diﬀerent biophysical properties. In
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oocytes plasma membranes have a ratio of charged/un-
charged lipid close to 90/10 [16], we can suspect that this is
what happens for BAPTA and DM-nitrophen when looking
at the tonic inhibition of the CaV2.1 Ca
2þ channel by G-
proteins, where removal of the inhibition was only seen with
these chelators and not with EGTA or EDTA. This would
suggest that active Ca2þ ions for this type of regulation are
located in the close vicinity of the membrane and escape the
chelation by EGTA. However, we should also kept in mind
the fact that speciﬁc changes in the mobility or the aﬃnity
of these chelators could occur by interactions with cyto-
plasmic components of large molecular weight [17] and
participate to these eﬀects. Interestingly, the eﬀects of
BAPTA and DM-nitrophen are not irreversible and some
washout of the inhibition slowly occurred with time (>45
min), probably owing to the slow diﬀusion of injected
BAPTA toward intracellular membranes, to its saturation by
calcium ﬂowing into the cytosol from Ca2þ channels or in-
ternal stores [18] or to interactions with cytoplasmic com-
ponent [17]. A similar mechanism appears to be at work in
the interaction of AP-2 proteins with membranes [19], which
is speciﬁcally inhibited by BAPTA and not EGTA. This
novel property of BAPTA can be of prime importance to
discriminate the role of membrane-bound versus free Ca2þ
in physiological processes.
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